Libre, Henry R.

HRN: 21-40-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/04/2022
06/08/2022
IV
4.5gm
QID
CAPMR; Empyema
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: